˘
DOGAN and C¸AGLI/Turk J Chem
˘
3.2.2. N -[1-(4-methoxyphenyl)propan-1-yl]-4-methylbenzenesulfonamide (2b)
Rf = 0.43 pentane/acetone 5:1; [α]D21 = –7.6 (c 0.25, CH2 Cl2) for 43% ee. Lit.9 [α]2D5 = – 80.1 (c 1.50,
CHCl3) for 90% ee. 1 H NMR δ 7.54 (d, J = 7.9 Hz, 2H), 7.13 (d, J = 7.4 Hz, 2H), 6.92 (d, J = 7.9 Hz,
2H), 6.68 (d, J = 8.2 Hz, 2H), 4.90 (d, J = 7.0 Hz, 1H), 4.13 (q, J = 7.2 Hz, 1H), 3.74 (s, 3H), 2.37 (s,
3H), 1.74 (dq, J = 45.4 Hz,J =8.3 Hz, 2H), 0.76 (t, J = 7.2 Hz, 3H); 13 C NMR δ 142.9, 132.8, 129.2, 127.7,
127.2, 114.8, 113.7, 59.6, 55.3, 30.5, 21.4, 10.4. HPLC: Chiralcel OD-H column, UV detection at 254 nm, eluent:
hexane/iPrOH 10:1, flow 0.6 mL min−1 , tR = 29.8 min (minor) and 34.4 min (major).
3.2.3. N -[1-(4-bromophenyl)propan-1-yl]-4-methylbenzenesulfonamide (2c)
Rf = 0.41 pentane/acetone 5:1; [α]D21 = –20.9 (c 0.25, CH2 Cl2) for 56% ee. Lit.9 [α]2D5 = –25.5 (c 1.25,
CHCl3) for 92% ee. 1 H NMR δ 7.49 (d, J = 7.9 Hz, 2H), 7.26 (d, J = 7.3 Hz, 2H), 7.13 (d, J = 7.9 Hz,
2H), 6.88 (d, J = 7.3 Hz, 2H), 4.80 (d, J = 7.0 Hz, 1H), 4.17 (q, J = 7.2 Hz, 1H), 2.38 (s, 3H), 1.70 (dq, J =
45.0 Hz, J = 7.6 Hz, 2H), 0.78 (t, J = 7.5 Hz, 3H); 13 C NMR δ 141.2, 131.4, 129.3, 128.4, 126.9, 121.2, 59.2,
30.3, 21.4, 10.4. HPLC: Chiralpak AS-H column, UV detection at 254 nm, eluent: hexane/iPrOH 75:25, flow
0.7 mL min−1 , tR = 30.7 min (minor) and 54.8 min (major).
3.2.4. N -[1-(1-naphthylmethylene)propan-1-yl]-4-methylbenzenesulfonamide (2d)9
Rf = 0.52 pentane/acetone 5:1. 1 H NMR δ 7.82–7.23 (m, 9H), 6.88 (d, J = 8.0 Hz, 2H), 5.23 (d, J = 7.7
Hz, 1H), 5.04 (q, J = 7.2 Hz, 1H), 2.45 (s, 3H), 1.94 (dq, J =14.6 Hz,J =4.3 Hz, 2H), 0.85 (t, J = 7.5 Hz,
3H); 13 C NMR δ 142.8, 142.6, 133.7, 131.3, 131.2, 130.6, 129.8, 129.1, 128.9, 128.7, 127.8, 127.3, 126.8, 126.7,
126.1, 126.0, 125.5, 125.2, 125.1, 123.9, 123.2, 122.6, 55.8, 45.4, 30.4, 21.2, 10.7. HPLC: Chiralpak AD column,
UV detection at 254 nm, eluent: hexane/iPrOH 85:15, flow 0.7 mL min−1 , tR = 19.1 min (minor) and 24.2
min (major).
3.2.5. N -[1-(2-naphthylmethylene)propan-1-yl]-4-methylbenzenesulfonamide (2e)7
Rf = 0.47 pentane/acetone 5:1, [α]2D1 = –8.8 (c 0.25, CH2 Cl2) for 12% ee. 1 H NMR δ 7.69–7.27 (m, 8H),
7.06 (dd, J = 8.6 Hz,J =1.84 Hz, 1H), 6.84 (d, J = 8.1 Hz, 2H), 4.94 (d, J = 7.6 Hz, 1H), 4.28 (q, J = 7.3
Hz, 1H), 2.09 (s, 3H), 1.78 (dq, J = 40.4 Hz, J = 7.53 Hz, 2H), 0.76 (t, J = 7.4 Hz, 3H); 13 C NMR δ 142.8,
142.6, 135.8, 128.5, 128.4, 127.7, 127.5, 127.0, 126.5, 126.4, 126.0, 125.9, 124.9, 124.8, 124.7, 124.0, 122.6, 59.9,
46.4, 30.4, 21.5, 10.8. HPLC: Chiralpak AD column, UV detection at 254 nm, eluent: hexane/iPrOH 85:15,
flow 0.7 mL min−1 , tR = 21.5 min (minor) and 29.0 min (major).
3.2.6. N -[1-(2-naphthyl)propyl]-P,P-diphenylphosphinic amide (2f)11
Rf = 0.30 pentane/acetone 5:1. 1 H NMR δ 7.91–7.75 (m, 3H), 7.65 (d, J = 7.7 Hz, 2H), 7.47–7.22 (m, 10H),
6.91 (d, J = 8.0 Hz, 2H), 5.04 (q, J = 7.0 Hz, 1H), 4.97 (d, J = 7.3 Hz, 1H), 1.96 (dq, J = 14.4 Hz, J =3.5
Hz, 2H), 0.86 (t, J = 7.5 Hz, 3H); 13 C NMR δ 133.2, 133.1, 133.1, 133.0, 131.7, 128.9, 128.8, 128.7, 58.1, 31.4
(JC−P = 4.8 Hz), 18.2 (JC−P = 5.3 Hz), 10.8. HPLC: Chiralpak AD column, UV detection at 254 nm, eluent:
hexane/iPrOH 80:20, flow 1.0 mL min−1 , tR = 10.3 min (minor) and 12.7 min (major).
295